Tempus Launches Prospective “Priority” Research Study and Increases Support for Oncology Research Initiatives Despite Pandemic Challenges
June 01, 2020 10:18 ET
|
Tempus
CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its...
Tempus Launches New Precision Medicine-Driven Tests: Tempus|HRD and Tempus|TO
May 31, 2020 10:30 ET
|
Tempus
CHICAGO, May 31, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch...
Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology
May 30, 2020 10:30 ET
|
Tempus
CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of...
Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones
May 29, 2020 15:55 ET
|
Tempus
CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors
October 29, 2019 11:00 ET
|
Tempus
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that...
Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities
September 30, 2019 11:00 ET
|
Tempus
CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a...
Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs
September 03, 2019 13:00 ET
|
Tempus
CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the...
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
August 22, 2019 12:00 ET
|
Tempus
CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the...
Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
June 11, 2019 08:00 ET
|
Tempus
CHICAGO, June 11, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that...
Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials
June 03, 2019 10:30 ET
|
Tempus
CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a...